目錄:MedChemExpress LLC>>信號通路>> JH-X-119-01 | MCE
CAS | 2227368-54-7 | 純度 | ≥98.0% |
---|---|---|---|
分子量 | 452.46 | 分子式 | C??H??N?O? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 5 mg |
貨號 | HY-103017A | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。
產(chǎn)品活性:JH-X-119-01 是一種有效的選擇性白介素 1 受體相關(guān)激酶 1 (IRAK1) 抑制劑。JH-X-119-01 可改善 LPS 誘導(dǎo)的小鼠敗血癥。JH-X-119-01 抑制 IRAK1,IC50 為 9 nM,而在濃度高達(dá) 10 μM 時(shí)對 IRAK4 也沒有抑制作用。
研究領(lǐng)域:Immunology/Inflammation
作用靶點(diǎn):IRAK
In Vitro: JH-X-119-01 (10 μM) decreases phosphorylation of NF-κB and mRNA levels of IL-6 and TNFα in LPS-treated macrophages in vitro. JH-X-119-01 selectively inhibits IRAK1 phosphorylation.JH-X-119-01 exhibits off-target inhibition of only two additional kinases, YSK4 and MEK3. Dose response analysis reveals an IC50 of 57 nM for YSK4.JH-X-119-01 shows moderate cell killing effects in a panel of Waldenstr?m’s macroglobulinemia (WM) cells, Diffused Large B-cell Lymphoma (DLBCL) cells, and lymphoma cells expressing mutant MYD88, with EC50s ranging from 0.59 to 9.72 μM.
In Vivo: JH-X-119-01 improves survival and decreases immunopathies of LPS-challenged mice. JH-X-119-01 increases survival of mice at the dose of 5 mg/kg body weight. Survival is further improved when the dose is increased to 10 mg/kg.
相關(guān)產(chǎn)品:Bioactive Compound Library Plus | Anti-Infection Compound Library | Immunology/Inflammation Compound Library | Kinase Inhibitor Library | Anti-Cancer Compound Library | Anti-Blood Cancer Compound Library | Heterocyclic Compound Library | Cysteine Targeted Covalent Library | IRAK4-IN-4 | HS-276 | HS-243 | IRAK inhibitor 2 | IRAK4-IN-14 | HG-12-6 | IRAK4-IN-13 | Zabedosertib | KTX-612 | IRAK inhibitor 6 | KTX-582 | IRAK4-IN-19 | AZ1495 | IRAK4-IN-1 | IRAK4-IN-21 | PROTAC IRAK4 degrader-5 | IRAK4-IN-17 | IRAK4-IN-12 | PROTAC IRAK4 degrader-6 | KTX-951 | IRAK4-IN-22 | IRAK4-IN-11 | JH-X-119-01 hydrochloride | PF-06426779 | JNJ-1013 | IRAK4-IN-16 | Ginsenoside Rb1 | KTX-497 | IRAK-1-4 Inhibitor I
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種全球僅有化合物庫,我們致力于為全球科研客戶提供前沿的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動(dòng)劑涉及各熱門信號通路及疾病領(lǐng);
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項(xiàng)目;
• 提供虛擬篩選,離子通道篩選,代謝組學(xué)分析檢測分析,藥物篩選等專業(yè)技術(shù)服務(wù);
• 設(shè)有專業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控、驗(yàn)證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項(xiàng)質(zhì)檢報(bào)告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實(shí)驗(yàn)驗(yàn)證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團(tuán)隊(duì)跟蹤最新的制藥及生命科學(xué)研究進(jìn)展,為您提供全球新的活性化合物;
• 與世界各大制藥公司及著名科研機(jī)構(gòu)建立了長期的合作。
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)